The global capnography device market size was valued at USD 778 million in 2025 and is projected to grow from USD 851.91 million in 2026 to USD 1760.79 million by 2034, registering a CAGR of 9.5% during the forecast period from 2026 to 2034. North America dominated the capnography device market with a market share of 39.2% in 2025.
Capnography devices are medical instruments that continuously measure and monitor the concentration or partial pressure of carbon dioxide (CO₂) in a patient's exhaled breath. They provide real-time information about respiratory status, ventilation efficiency, and airway function through numerical values and graphical waveforms. These devices are widely used during anesthesia, intensive care, emergency medicine, and procedural sedation to detect breathing abnormalities, verify airway placement, monitor patient safety, and support timely clinical decision-making.
Download a Free Sample To learn more about this report,
Capnography Is Becoming More Integrated With Multiparameter Patient Monitoring
The need for a broader view of respiratory status is increasing demand for devices that combine carbon dioxide, oxygen saturation, respiratory rate, and pulse measurements in one monitoring platform. This transition is bringing capnography into multiparameter systems, with Medtronic's Capnostream 35 combining etCO₂, SpO₂, respiratory rate, and pulse rate through its Integrated Pulmonary Index. The outcome is more consolidated patient monitoring that can provide clinicians with a broader assessment of respiratory condition from a single device.
Portable Capnography Is Becoming More Connected to Emergency-Care Workflows
The capnography device market analysis shows that the need for continuous respiratory monitoring during patient movement and emergency transport is increasing demand for compact devices that combine portability, multiple measurements, and data connectivity. This transition is supporting rugged capnography platforms for EMS and intra-hospital transport, with the Capnostream 35 combining Microstream capnography and pulse oximetry and offering Wi-Fi connectivity for data management and remote monitoring. The outcome is greater integration of capnography into emergency and transport workflows, including ground and air ambulance applications.
Expansion of Procedural Sedation and Anesthesia Services and Increasing Respiratory Disease Burden Drive Capnography Device Market
The expansion of surgical, endoscopic, dental, and anesthesia procedures increases demand for capnography devices because continuous ventilation assessment is required during sedation and anesthesia. Greater use of sedation in outpatient procedures creates additional procurement needs across hospitals, ambulatory surgical centers, and specialty clinics. For example, an endoscopy center can use capnography to monitor a sedated patient’s ventilation throughout a procedure. This wider procedural use supports recurring demand for capnography devices and related monitoring accessories.
A higher burden of respiratory diseases increases demand for capnography devices used to assess ventilation and monitor patients with impaired respiratory function. Patients with COPD, acute respiratory failure, or other breathing disorders may require repeated or continuous carbon dioxide monitoring during treatment. For example, intensive care units can use capnography to assess ventilation in patients receiving respiratory support. This broader clinical requirement expands device procurement across emergency, critical-care, and respiratory-care settings.
Reimbursement and Budget Constraints and Limited Awareness of Capnography Benefits Restrain Market Expansion
Reimbursement and budget constraints can limit healthcare providers’ ability to purchase capnography devices when reimbursement coverage is limited, or equipment budgets are restricted. Higher acquisition and operating costs can encourage facilities to prioritize essential monitoring equipment over additional capnography systems. Consequently, limited financial support can slow adoption and constrain market growth.
Limited awareness of capnography benefits can reduce understanding of its role in respiratory monitoring, anesthesia, emergency care, and critical care applications. Lower awareness among healthcare providers and decision-makers can reduce demand and delay investment in capnography equipment. As a result, limited clinical awareness can slow market penetration and restrict market expansion.
Capnography for Neonatal and Pediatric Care and Capnography Solutions for Home-Based Respiratory Care Offer Growth Opportunities
Neonatal intensive care units, pediatric hospitals, and specialized healthcare providers are key customers for capnography devices designed for smaller patients. Companies such as Masimo and Medtronic can expand revenue through specialized sensors, pediatric monitoring systems, and long-term hospital procurement agreements.
Home healthcare providers, respiratory clinics, and medical device distributors are key customers for compact capnography solutions used in home-based respiratory monitoring. Companies such as Masimo can generate revenue through portable devices, recurring sensor and consumable sales, and partnerships with home-care providers, contributing to capnography device market growth.
Device Integration Challenges and Evolving Clinical Requirements and Sensor Accuracy and Maintenance Requirements Hinder Growth
Capnography devices must integrate with patient monitors, anesthesia machines, ventilators, and other clinical systems while adapting to different hospital workflows and evolving clinical requirements. Compatibility and validation across diverse equipment increase development complexity and implementation time, making it harder for manufacturers to standardize products and expand across healthcare facilities.
Sensor accuracy can be affected by moisture, airway secretions, patient movement, and variations in respiratory conditions, requiring reliable sensors and sampling components for consistent measurements. Calibration, sensor replacement, and routine maintenance increase operational requirements for healthcare providers, making widespread deployment more difficult and limiting the scalability of capnography solutions.
The multiparameter capnometers segment accounted for a market share of 28.6% in 2025 due to its ability to monitor end-tidal carbon dioxide alongside other vital physiological parameters through a single device. Integration of multiple monitoring functions supports clinical decision-making and makes these systems suitable for anesthesia, critical care, emergency care, and procedural settings.
The capnography accessories & disposables segment is expected to grow at a CAGR of 9.6% during the forecast period 2026-2034, driven by the recurring need for sampling lines, airway adapters, filters, and other consumable components used with capnography systems. Regular replacement requirements and continued device utilization support recurring demand for these products.
The capnometers segment provides direct measurement and monitoring of carbon dioxide levels during patient care. Their use in respiratory monitoring, anesthesia, and emergency settings supports continued demand for compact and reliable capnography devices. The standalone capnometers segment offers dedicated carbon dioxide monitoring without combining multiple physiological measurements within the same device. Focused functionality and suitability for applications requiring dedicated respiratory monitoring support their use across clinical environments.
Request Customizationto receive a tailored report.
The OEM modules segment is expected to grow at a CAGR of 9.7% during the forecast period 2026-2034, driven by the integration of capnography technology into patient monitoring systems, anesthesia equipment, and other medical devices. Demand for compact, application-specific monitoring modules enables manufacturers to incorporate carbon dioxide measurement capabilities into a broader range of clinical equipment.
The sidestream segment accounted for a market share of 48.6% in 2025 due to its ability to continuously monitor carbon dioxide levels through a sampling line while keeping the sensor away from the patient airway. Flexible application across anesthesia, critical care, and respiratory monitoring supports its strong position in clinical settings.
The microstream segment is expected to grow at a CAGR of 10.6% during the forecast period 2026-2034, driven by its low-flow sampling technology and suitability for patients requiring efficient carbon dioxide monitoring. Compact sensor configurations and compatibility with various patient monitoring applications support its adoption across clinical environments. The mainstream segment measures carbon dioxide directly at the airway, enabling rapid and continuous monitoring of respiratory gases. Direct measurement provides fast response times, supporting its use in anesthesia, emergency care, and critical care applications.
The trauma and emergency care segment is expected to grow at a CAGR of 10.2% during the forecast period 2026-2034, driven by the need for rapid respiratory assessment and continuous carbon dioxide monitoring during emergency interventions. Capnography supports airway management, ventilation assessment, and patient monitoring during trauma treatment, creating demand for these devices in emergency care settings.
The respiratory monitoring segment accounted for a market share of 36.8% in 2025 due to the use of capnography for continuous assessment of ventilation and carbon dioxide levels in patients with respiratory conditions. Integration into critical care, anesthesia, and respiratory management workflows supports its significant market position. The cardiac care segment uses capnography to monitor ventilation and end-tidal carbon dioxide during cardiac procedures and resuscitation. Continuous respiratory assessment helps clinicians evaluate ventilation status and patient response during cardiac care interventions.
The hospitals segment accounted for a market share of 72.6% in 2025 due to the extensive use of capnography devices for anesthesia, critical care, respiratory monitoring, emergency treatment, and surgical procedures. The need for continuous carbon dioxide monitoring across diverse hospital departments supports its dominant position in the market.
The ambulatory care centers segment is expected to grow at a CAGR of 10.1% during the forecast period 2026-2034, driven by the adoption of capnography for outpatient procedures, sedation, and respiratory monitoring. The shift toward shorter procedures and decentralized care supports demand for compact and efficient capnography devices in ambulatory settings.
Speak to an Analystto discuss market opportunities.
The North America capnography device market accounted for the largest regional share of 39.2% in 2025, supported by advanced hospital infrastructure, high volumes of surgical and procedural sedation services, and established use of continuous respiratory monitoring in anesthesia, emergency care, and critical-care settings.
The US capnography device market will be supported by continued demand for respiratory and anesthesia care, with the U.S. anesthesia and respiratory devices market projected to reach $16.99 billion by 2030, reflecting expanding demand for respiratory monitoring technologies. The Canada capnography device market will be influenced by population ageing, with people aged 65 and older projected to represent 21.4%–23.4% of Canada’s population by 2030, while the number of people aged 85 and older is projected to reach 2.5–3.0 million by 2050, increasing the need for respiratory and hospital-based monitoring services.
Unlock Regional Insightsto access country-level data, & regional trends.
The Europe capnography device market is expected to grow at a CAGR of 10.8% during 2026–2034, making it the fastest-growing regional market, supported by the region’s ageing population and increasing demand for respiratory monitoring, with the European Commission projecting that the share of people aged 65 and older will reach around 30% of the EU population by 2050.
The UK capnography device market will be supported by a projected UK population of 69.2 million by 2030 and 71.0 million by 2045, expanding the overall healthcare service base and potential demand for respiratory monitoring equipment. The Germany capnography device market will be influenced by population ageing, with one-quarter of Germany’s population projected to be aged 67 or older by 2035, while the number of people aged 67 and over is projected to reach 20.5–21.3 million by 2038, increasing demand for hospital and respiratory-care services. The France capnography device market will benefit from an ageing population, with people aged 65–74 projected to account for 11.3% and those aged 75 and over 12.3% of the population by 2030, increasing the potential need for hospital-based respiratory monitoring and critical-care services.
The Asia Pacific capnography device market accounted for a regional share of 22.1% in 2025, supported by expanding healthcare infrastructure, increasing demand for respiratory monitoring, and the region’s large and ageing patient population.
Japan’s capnography device market will be supported by population ageing, with people aged 65 and above projected to account for 38.7% of Japan’s population by 2070, while life expectancy is projected to reach 85.89 years for men and 91.94 years for women, increasing demand for hospital and respiratory monitoring services. China’s capnography device market will be influenced by rapid population ageing, with people aged 60 and above projected to account for about 30% of the population by 2035, expanding the potential need for respiratory monitoring and hospital-based care.
South Korea’s capnography device market will benefit from demographic ageing, with people aged 65 and above projected to account for 30% of the population by 2036 and more than 40% by 2050, increasing demand for healthcare and respiratory monitoring services. India’s capnography device market will be supported by demographic ageing, with the population aged 60 and above projected to reach 230 million by 2036, representing 14.9% of the total population, expanding the long-term healthcare and monitoring service base.
The capnography device market is moderately fragmented, with large medical device manufacturers, patient-monitoring companies, anesthesia equipment providers, respiratory monitoring specialists, and regional medical technology suppliers competing across hospitals, emergency care, procedural sedation, intensive care, and transport applications. Key players such as Medtronic, Philips, Masimo Corporation, Drägerwerk AG & Co. KGaA, and Nihon Kohden collectively are estimated to account for approximately 45% of the global capnography device market share.
Established players compete on measurement accuracy, sensor and sampling technology, clinical reliability, product portfolios, hospital relationships, and global distribution, while emerging and regional players in the capnography device market ecosystem compete through compact and portable designs, wireless connectivity, simplified workflows, application-specific solutions, flexible configurations, and faster customization. Competition also centers on sidestream and mainstream technologies, integration of capnography with broader vital-sign monitoring, and the ability to support different patient populations and clinical environments.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Germany Surgical Equipment Market Size, Share and Forecast to 2034
Europe Surgical Equipment Market Size, Top Share and Forecast to 2034
Plasmapheresis Machines Market Size, Share, Growth, Analysis, 2034
Facial Cleansing Devices Market Size, Share, Growth, Analysis, 2034
Wearable Fitness Trackers Market Size, Share, Growth, Analysis, 2034
Bariatric Surgery Devices Market Size, Share, Growth, 2034
We are featured on:
sales@straitsresearch.com